The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
I'm a litigation reporter for Connecticut Law Tribune, covering litigation wins, verdict news, settlements, interesting cases, etc. Contact me with tips at ecousins@alm.com.
At least five privacy class actions were filed against Blue Shield of California on Thursday after the health insurance company announced Google Analytics had tracked and shared members' medical information and other personal data with Google Ads.
Aetna Inc., The Cigna Group, Elevance Health Inc., Humana Inc., Zelis Claims Integrity LLC, Seliz Network Solutions and Zelis Healthcare were accused in multiple antitrust class actions of working together to suppress payments to out-of-network medical providers.
Texas representatives grilled the CEO of Superior HealthPlan, Mark Sanders, for emails allegedly showing he had hired private investigators to watch state representatives, a journalist and private citizens seeking health care coverage.
CVS has been hit with at least three federal class actions, including two antitrust cases accusing CVS Caremark Corp. and other pharmacy benefit managers, the intermediaries between insurance companies and pharmacies, of price-fixing prescription drug reimbursement rates.
Class action lawsuits alleging violations of the Employee Retirement Income Security Act of 1974 are on the rise nationally against companies allegedly charging a higher premium for policyholders who use tobacco.
"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given drug-device combination unless the generic is approved for that specific drug-device combination," the complaint alleged.
Boehringer Ingelheim, one of 10 companies sent a warning letter by the FTC disputing the accuracy of patent listings in the FDA's Orange Book, was hit with an class action lawsuit, alleging that the company is using expired patents.
The health fund for the International Union of Operating Engineers is suing Eli Lilly, Novo Nordisk and Sanofi, as well as CVS Health and other PBMs, for "drastically" increasing the price of life-saving meds for "illicit profits."